Evidence map›Paper›PMID 18193455›Full record

ArticleParasitology research2008

Leishmania major infection in susceptible and resistant mice elicit a differential humoral response against a total soluble fraction and defined recombinant antigens of the parasite.

Virginia Iniesta, Inés Corraliza, Jesualdo Carcelén, Luis Gómez Gordo, Javier Fernández-Cotrina, Juan Carlos Parejo, Javier Carrión, Manuel Soto, Carlos Alonso, Carlos Gómez Nieto

Abstract read
PubMed Publisher
In one paragraph

Article in Parasitology research, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 10 citations in OpenAlex.

  1. Candidate antigens for serological testing (ELISA) and diagnosis of canine visceral leishmaniasis.Revista brasileira de parasitologia veterinaria = Brazilian journal of veterinary parasitology : Orgao Oficial do Colegio Brasileiro de Parasitologia Veterinaria · 2025
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Virginia IniestaUnidad de Parasitología y Enfermedades Parasitarias, Universidad de Extremadura, Avda. de la Universidad s/n, 10.071, Cáceres, Spain. viniesta@unex.es
Inés Corraliza
Jesualdo Carcelén
Luis Gómez Gordo
Javier Fernández-Cotrina
Juan Carlos Parejo
Javier Carrión
Manuel Soto
Carlos Alonso
Carlos Gómez Nieto
Universidad de Extremadura · ESCentro de Biología Molecular Severo Ochoa · ESUniversidad Autónoma de Madrid · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the present work, we analyzed the humoral response of Leishmania major experimentally infected BALB/c and C57BL/6 mice against three Leishmania antigens: total soluble antigen (soluble leishmania antigen(SLA)), a chimerical recombinant protein formed by the genetic fusion of four cytoplasmic proteins (PQ), and a kinetoplastic membrane protein (Kmp-11). We determined the correlation between the immune response against these proteins and the histopathological changes induced in the susceptible and resistant mice after infection. The data showed the existence of wide differences in the recognition of SLA, PQ, and Kmp-11 by the sera from both strains. The anti-SLA titer of BALB/c was 100 times higher than that of C57BL/6 mice. Antibodies against the recombinant Kmp-11 were detected only in infected BALB/c during the first stage of the infection. In contrast, the PQ protein was recognized by the sera from infected BALB/c mice but exclusively when they were in a late-lesion period. The data suggest that the response against the membrane Kmp-11 protein is transient and correlates with early developmental stages of the infection, whereas the response against cytoplasmic proteins as those present in PQ is sustained and could be considered as a marker of an advanced stage of the infection and disease.

Indexed as

Antibody SpecificityAnimalsAntibodies, ProtozoanAntigens, ProtozoanDisease SusceptibilityFootHumansImmunoglobulin GLeishmania majorLeishmaniasisMembrane GlycoproteinsMiceMice, Inbred BALB CMice, Inbred C57BLProtozoan ProteinsRecombinant Fusion ProteinsAntibodies, ProtozoanAntigens, ProtozoanImmunoglobulin GMembrane GlycoproteinsProtozoan ProteinsRecombinant Fusion Proteins

Identifiers

PMID18193455
OpenAlexW2050678525

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.